Inmunómica traslacional en neoplasias hematológicas
Instituto de Investigación Sanitaria La Fe
Valencia, EspañaInstituto de Investigación Sanitaria La Fe-ko ikertzaileekin lankidetzan egindako argitalpenak (5)
2022
-
Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 40, Núm. 27, pp. 3151-3161
2021
-
Profiles of patients with venous thromboembolic disease in the emergency department and their medium-term prognosis: Data from the ESPHERIA registry
Emergencias, Vol. 33, Núm. 2, pp. 107-114
-
Reference values to assess hemodilution and warn of potential false-negative minimal residual disease results in myeloma
Cancers, Vol. 13, Núm. 19
2019
-
Identification of 58 mutations (26 Novel) in 94 of 109 symptomatic Spanish probands with protein C deficiency
Thrombosis and Haemostasis, Vol. 119, Núm. 9, pp. 1409-1418
2013
-
NIK controls classical and alternative NF-κB activation and is necessary for the survival of human T-cell lymphoma cells
Clinical Cancer Research, Vol. 19, Núm. 9, pp. 2319-2330